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Abstract
Occupational and environmental acne is a dermatological disorder associated with
industrial exposure. Polyhalogenated hydrocarbons, coal tar and products, petrol, and
other physical, chemical, and environmental agents are suggested to play a role in the
etiology of occupational acne. The people working in the field of machine, chemistry,
and  electrical  industry  are  at  high  risk.  The  various  occupational  acne  includes
chloracne, coal tar, and oil acne. The most common type in clinic is the comedones, and
it is also seen as papule, pustule, and cystic lesions. Histopathological examination
shows epidermal hyperplasia, while follicular and sebaceous glands are replaced by
keratinized epidermal cells. Topical or oral retinoic acids and oral antibiotics could be
used  in  treatment.  The  improvement  in  working  conditions,  taking  preventive
measures, and education of the workers could eliminate occupational acne as a problem.
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1. Introduction
Occupational and environmental acne is a dermatological disorder associated with industrial
exposure. Polyhalogenated hydrocarbons, coal tar and products, petrol, and other physical,
chemical, and environmental agents are suggested to play a role in the etiology of occupational
acne [1]. The people working in the field of machine, chemistry and electrical industry are at
high  risk  [2].  The  various  occupational  acne  includes  chloracne,  coal  tar,  and  oil  acne.
Chloracne is an acneiform eruption that is observed as a result of intoxication with chlorinated
hydrocarbons [3] and clinical signs might be severe [4]. It could also arise due to industrial,
agricultural, and environmental contamination and even due to eating contaminated foods [2].
Oils used in the industry such as cutting oils (paraffin/oil mixtures), tars (pitch and creosote),
and crude petroleum oil (diesel oil) can cause oil and tar acne. Occupational acne is a type of
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acne that develops as a result of exposure to insoluble materials causing follicle obstruction.
The most common clinical feature is the open and closed comedones, noninflamed nodules,
and cystic lesions [5]. Histopathological examination shows epidermal hyperplasia, while
follicular and sebaceous glands are replaced by keratinized epidermal cells. [6] In occupational
acne, contact should be prevented in individuals working at high risk. In case of contact, the
chemical agent should be removed. Topical or oral retinoic acids and oral antibiotics could be
used for treatment [7].
2. Classification of occupational acne
2.1. Chloracne
2.1.1. Introduction
Chloracne was first defined by Herxheimer in 1889 [8]. Occupational acne is considered one
of the sensitive indicators of systemic intoxication caused by an exposure to certain halogen-
ated aromatic hydrocarbons called chloracnegen. Although the majority of cases with chlor-
acnegen intoxication are associated with occupational exposure, there are also cases with
chloracnegen intoxication associated with non-occupational exposure to the industrial wastes
and contaminated foods [6].
2.1.2. Etiology
Halogenated aromatic hydrocarbons are the most potent chloracnegen agents [9]. Poly-
chlorinated naphthalenes, polychlorinated biphenyls (PBBs), polychlorinated dibenzofur-
ans (PCDFs), polychlorinated phenols, contaminants of polychlorophenol compounds
(especially herbicides), and chlorinated azo- and azoxybenzene are among the chloracne-
gens [2]. Electrical conductor and insulators, insecticide, fungicide, herbicide, and wood
protectors are the agents that cause chloracne [7]. With the introduction of synthetic resins
in the 1960s, a high incidence of chloracne after the exposure to polychlorinated naphtha-
lenes and PCBs showed a decline. In later years, the majority of cases exposed to chloracne-
gens were caused by accidents [10, 11]. The condition has been recently reported in
chemical industry workers exposed to chloracne chlorophenols [12, 13] and agricultural
workers exposed to pesticides [14].
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), which is the prototype of polyhalogenated
aromatic hydrocarbons is an important cause of chloracne [9]. In the 1970s, chloracne outbreak
occurred in a chemical plant in Austria after the exposure of mostly male workers to TCDD,
and the workplace was closed for cleaning and reconstruction activities to take place [15]. In
1976, an accident occurred in a chemical plant in Seveso (Italy), known as “ICMESA plant
explosion,” and 2 kg TCDD was released to the atmosphere, causing chloracne outbreak which
mostly affected children [11]. In addition, PCBs and PCDFs are other chloracnegens, and PCBs
have been shown to result in direct toxicity by contaminating the cooking oil, and transpla-
cental transmission has also been demonstrated [9]. The largest food pollution of Japan which
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occurred in 1968 and currently known as “Yusho” has developed due to the contamination of
rice bran oil with polychlorinated hydrocarbons, and it is remembered as an intoxication of a
crowd. Although initial analyses failed to detect a chemical substance, biopsy samples
obtained from the fat tissues showed deposition of PCBs [16]. In 1979, the incidence of
chloracne was reported to be 17.5% in 2000 patients with Yucheng disease (oil disease), which
resulted from consuming the food products contaminated by PCBs and PCDFs in Taiwan [17].
Earlier, PCBs have been used frequently as wood preservatives [18].
In modern times, occupational exposure to PCBs often occurs in the fields of construction,
paint, ink, adhesive, paper products [19–21], mining, recycling and waste incineration, and
hydraulic and transformer systems [22]. Furthermore, PCBs have been detected in plasma
and exhaled air in individuals exposed to power transformer oil spilled after an accident
during the shipment of the waste products, and these individuals also suffered from acnei-
form skin lesions [23]. On the other hand, Gawkrodger et al. [24] reported chloracne out-
break in seven chemists working in the pharmaceutical industry exposed to
triazoloquinoxaline, a polycyclic halogenated chemical substance, which was not previously
reported in association with chloracne. In addition, weed killer containing 2,4-dichloro- and
2,4,5-trichlorophenoxyacetic acid and sodium tetrachlorophenate used for the wood preser-
vatives are the other chloracnegens [9].
2.1.3. Pathogenesis
Although cellular and molecular mechanisms still remain to be elucidated, the major effect is
hypoplastic or hyperplastic response of the skin caused by cellular changes triggered by
chloracnegens. Epidermis and infundibulum are also involved. Sebaceous and sweat glands
lose their secretory functions and are replaced by keratinized cells. According to the epidermal
stem cell theory of Panteleyev, chloracnegens activate epidermal stem cells which result in the
transformation of the pilosebaceous unit by accelerating the cellular output [3]. TCDD
demonstrates its biological effect by binding to cytosolic aryl hydrocarbon receptors. Exposure
to TCDD increases keratinocyte proliferation [2].
Genetic studies carried out in patients with chloracne evaluated aryl-hydrocarbon receptor
(AhR), transcription, and downstream genes such as CYP1A1, GSTA1, c-fos, and TGF-α
expression in the epidermis using the real-time PCR method. These studies showed a high
AhR, CYP1A1, GSTA1, and c-fos transactivation in the epidermal tissue associated with long-
term exposure to TCDD and dibenzofuran. Therefore, AhR activation has been suggested to
play an important role in the pathogenesis of the chloracne pathway and that increased activity
might disrupt the normal epidermal cellular proliferation and differentiation [25].
2.1.4. Clinical features
The lesions appear as erythema and edema in the affected areas such as head, neck, malar and
retroauricular, and mandibular areas, extremities, axilla, trunk, hip, and scrotum 2–4 weeks
after exposure [10] and, then, turn into non-inflammatory black and white comedones and




non-infectious abscess, and scar formation after healing can be observed in severe cases. In
addition, the lesions can relapse [7, 26, 27] and become generalized. Chloracne has a chronic
disease course, and the severity of the disease is associated with the exposure dose, potency
of the chloracnegen, and individual susceptibility [6]. A correlation has been reported between
half-life and body mass index, body fat mass, TCDD mass, and chloracne response [28].
Systemic symptoms and severe chloracne may occur after the TCDD exposure [9]. Additional
dermatological findings may also present, such as brownish hyperpigmentation of the nails,
hypertrichosis, and hyperpigmentation in the involved areas. Severe cases may exhibit
symptoms of systemic intoxication, such as impaired liver functions, porphyria cutanea tarda,
and peripheral neuropathy [10], while some cases may suffer from fatigue, anorexia, impo-
tence, hyperlipidemia, anemia, arthritis, and ophthalmopathy [29]. Indeed, diagnostic criteria
for Yusho were established after Yusho disaster in Japan, and clinical findings were categorized
as subjective, ocular, dermatological manifestations, and overall symptoms. The most impor-
tant clinical manifestations of this situation have been chloracne and ocular damage [16].
Figure 1. Clinical photograph, showing a combination of small cysts, closed and open comedones, and some inflam-
matory papules.1
1 Reprinted from Wiley, 161,Gawkrodger DJ, Harris G, Bojar RA. Chloracne in seven organic chemists exposed to novel
polycyclic halogenated chemical compounds (triazoloquinoxalines), 939-943, 2009, with permission from John Wiley.
(reproduced with permission of the patient).
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Figure 2. Close up showing small cysts, keratin plugs in pores, and comedones in more detail.2
According to the diagnostic criteria revised in 2004, dermatological manifestations were
reported as acneiform eruptions and pigmentation (Table 1) [30]. It has been suggested that
Yucheng disease manifest with dermatological symptoms, such as hyperpigmentation and nail
changes, similar to chloracne; however, it may also manifest systemic symptoms such as
headache, neuropathy, goiter, arthritis, and anemia [17]. TCDD can stay in the body for many
years due to its high lipophilic characteristic and low metabolic rate [31]. Previous studies
reported a half-life of 7–11 years [32]. The lesions may persist for 15–30 years after the discon-
tinuation of the chloracnegen exposure [28]. In a study that was conducted in Japan, it was
reported that chloracne lesions stay in the body for more than 30 years and are correlated with
the blood levels of hydrocarbon [31]. In addition, TCDD was detected in the plasma of the
victims 20 years after the Seveso accident [11]. On the other hand, systemic toxicity develops
at higher doses than the dose necessary for the development of chloracne. Systemic toxicity is
not generally expected in the absence of chloracne [2]. Chloracne is accepted as a sensitive
marker of systemic absorption [27]. Hence Geusau et al. [33] detected generalized and severe
chloracne lesions together with systemic signs of severe TCDD intoxication and high blood
levels of TCDD in one of two female patients who have chloracne together with TCDD
intoxication, whereas they have detected moderate facial chloracne in spite of high blood levels
of TCDD and systemic signs in the other patient.
2 Reprinted from Wiley, 161,Gawkrodger DJ, Harris G, Bojar RA. Chloracne in seven organic chemists exposed to novel
polycyclic halogenated chemical compounds (triazoloquinoxalines), 939-943, 2009, with permission from John Wiley.




The diagnostic criteria for Yusho have been revised according to some changes in the symptoms and signs, as well as
advances in analytical techniques. The diagnostic criteria for Yusho were revised on October 26, 1972. A supplement
was added to the diagnostic criteria on June 14, 1976, and the concentration of polychlorinated quarterphenyls (PCQs)
in the blood was added to the diagnostic criteria on June 16, 1981. The concentration of 2,3,4,7,8-penta-
chlorodibenzofuran (2,3,4,7,8-PeCDF) was added to the diagnostic criteria on September 29, 2004.
Conditions of the incident
• Proof that Kanemi® rice bran oil contaminated with PCBs was ingested.
• There are also some cases in which PCB is transferred from mothers with Yusho to their children.
• Familial occurrence is also seen in many cases.
Important manifestations
1. Acneiform eruptions
Black comedones seen on the face, buttocks, and other intertriginous sites; comedones with inflammatory
manifestations; and subcutaneous cysts with atheroma-like contents that tend to suppurate.
2. Pigmentation
Pigmentation of the face, palpebral conjunctivae, and nails of both the fingers and the toes (including babies).
3. Hypersecretion by the meibomian glands.
4. Unusual composition and concentration of PCBs in the blood.
5. Unusual concentration of PCQs in the blood (reference 1).
6. Unusual concentration of 2,3,4,7,8-PeCDF in the blood (reference 2).
Symptoms and signs
1. Subjective symptoms
• A feeling of lassitude
• A feeling of heaviness in the head or headache
• Paresthesia of the limbs (abnormal sensation)
• Increased eye discharge
• Cough and sputum
• Inconsistent abdominal pain
• Altered menstruation
2. Objective manifestations
• Manifestations of bronchitis
• Deformation of the nails
• Bursitis
• Increased neutral fat in the serum
• Serum γ-glutamyl transpeptidase (γ-GTP)
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• Decrease of serum bilirubin
• Neonatal small-for-date baby
• Growth retardation and dental abnormality (retarded eruption of permanent teeth)
Reference 1.
The following conclusions have been made in regard to the concentration of PCQs in the blood:
1. ≥0.1 ppb: an abnormally high concentration
2. 0.03–0.09 ppb: the boundary between high and normal concentrations
3. ≤0.02 ppb (detection limit): normal concentration
Reference 2.
The following conclusions have been made in regard to the concentration of 2,3,4,7,8-PeCDF in the blood:
1. ≥50 pg/g lipids: an abnormally high concentration
2. 30–50 pg/g lipids: slightly high concentration
3. ≤30 pg/g lipids: normal concentration
Both age and sex of patients should also be considered.
Notes:
• With reference to the above-mentioned conditions of the incident, symptoms, and manifestations, and taking into
account the age of the examinees and the temporal progress of their illness, a diagnosis is comprehensively made.
• These diagnostic criteria are to be used to determine whether a patient is affected by Yusho, but they do not necessarily
relate to its severity.
• In regard to the abnormal properties of PCBs and the concentrations of PCBs and 2,3,4,7,8-PeCDF in the blood, regional
differences as well as the patient’s occupation should also be considered.
• Measurements should be performed by inspection agencies recognized by the Study Group of Yusho, at which quality
control is carried out.
Table 1. Diagnostic criteria for Yusho (2004)3.
2.1.5. Pathology
Histopathologically, hyperplasia in outer root sheath keratinocytes and the sebaceous canal is
the first sign. Hyperplastic outer root sheath and hyperkeratinized dilated follicle structure
are observed in the proximal part of the infundibulum of the involved hair follicles. Dilated
infundibulum is filled with keratinized cells and comedones consisting of sebum. Sebaceous
glands have disappeared or they have become quite small. Then the wall of the hair follicles
gets thinner and abscess formation develops due to rupture toward dermis (Figure 3).
3. Reprinted from Elsevier, 82, Mitoma C, Uchi H, Tsukimori K, Yamada H, Akahane M, Imamura T, Utani A, Furue M,





Furthermore, TCDD has been suggested to be a factor irritating directly the follicular wall and
determining atypical keratinization and squamous metaplasia in the follicle epithelium. The
involution of the sebaceous glands is not a direct chemical effect, but rather a condition
secondary to the follicular obstruction [2]. Hyperpigmentation due to increased melanin
production throughout the epidermis and epithelial basal layer of infundibulum has been
reported [34]. From the perspective of dermatopathology, chloracne must be differentiated
from acne vulgaris, nodular elastosis accompanied by cysts and comedones (Favre-Racouchot
syndrome), acne rosacea, pilar keratosis, lichen planopilaris, chronic discoid lupus erythema-
tosus due to loss of sebaceous glands, and hyperpigmentation in the stratum corneum [35].
Figure 3. Mechanism of chloracne.4
2.1.6. Treatment
Chloracne may resolve gradually after the discontinuation of the chloracnegen exposure. It
often weakly responds to acne medications, such as retinoic acid and antibiotics [10]. Corti-
costeroids, dermabrasion, and electrodessication may yield success to a certain extent.
However, chloracne is resistant to therapy, and therefore, protection is of utmost importance
[6]. Earlier studies attempted to prevent the chloracnegen exposure and facilitate the elimina-
tion from the body. A study evaluated the fecal excretion of chloracnegen using a synthetic
dietary fat substitute called olestra [36]. Another study demonstrated 30-fold higher excretion
of chloracnegen with the use of olestra diet and calorie restriction [37].
4 Reprinted from Elsevier, 32, Yamamoto O, Tokura Y. Photocontact dermatitis and chloracne: two major occupational
and environmental skin diseases induced by different actions of halogenated chemicals, 85-94, 2003, with permission
from Elsevier.
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2.2. Coal-tar acne
2.2.1. Introduction
It is a form of acne due to the obstruction of sebaceous glands by the mixture of coal tar and
keratin products. In a study investigating the frequency of occupational dermatosis in Greece,
coal-tar acne was detected at a rate of 23% in workers exposed to coal tar [38].
2.2.2. Etiology
Coal tar is a fatty fluid that is dark brown-nearly black in color, heavier than water, with a
naphthalene-like odor and a sharp burning taste. This is a by-product that is formed as a result
of distillation of hazardous parts of coal. Creosote, coal tar pitch, crude naphthalene, and
anthracene oils are by-products of the coal tar, which are produced from the crude coal tar.
The exposure to the coal tar occurs through the respiratory and gastrointestinal tract and the
skin [39]. Coal tar was first described by Becker and Serle in 1681 and its use in dermatological
disorders was described by Fishel in 1894 and Goeckerman in 1925 [40]. Coal tar has anti-
inflammatory, antimicrobial, antipruritic, and cytostatic effects. Thus, for many decades it has
been used as a therapeutic agent in skin diseases, such as psoriasis, and dermatitis [41]. Coal
tar is also found in the cleansing bars, creams, gels, lotions, ointments, shampoo, and topical
solutions and suspensions [39]. On the other hand, occupation exposure is more prevalent than
the therapeutic use and environmental contamination [41]. Coal tar has a wide range of utility
in the industry and consumer products. It is used as fuel in open-hearth furnaces and furnaces
in the steel industry, as a filling material ingredient of surface coating formulations, and as a
modifying agent ingredient of epoxy-resin surface coatings [39]. Coal tar exposure usually
occurs in the workers working in the aluminum production, iron-steel foundry, coal tar
refinery, road paving, roof insulation, pavement seal coat, and wood surfaces painting [41].
Pitch and creosote is the cause of acne in canal and road construction workers [42].
2.2.3. Pathogenesis
Keratin production and accumulation of fatty fluid causes an obstruction of the sebaceous
glands and comedone formation [4, 41].
2.2.4. Clinical features
Clinically it is observed as multiple open comedones in the malar regions of face. The absence
of inflammatory papules and pustules and big yellow cysts helps to distinguish coal-tar acne
from oil acne and chloracne. It is found in extensor surfaces of the arm and thigh. The rela-
tionship between coal tar and periorbital comedone formation was investigated and the
incidence of periorbital comedone was found to be high in people exposed to coal tar [1]. Under
the experimental conditions, crude coal tar was reported to show a higher inflammatory





There are widened follicular openings with keratin plugs and there are no inflammatory
infiltrates [1].
2.2.6. Treatment
Cold tar workers were recommended avoiding hazardous doses of exposure, wearing
protective work clothes, receiving training on how to keep their outwear clean with frequent
changing, using cleansers at the work places, working equipped with shower facilities and
ventilation systems, and undergoing regular health check-ups. The response to therapy was
reported to be higher than in chloracne [4, 41].
2.3. Oil acne
2.3.1. Introduction
Oil acne is the most common type of occupational acne [5]. Oil acne generally develops in
people exposed to oil circuit breaker. It is due to oil circuit breaker and grease oil, which are
used to lubricate machines and which contains a great amount of insoluble mineral oil [1].
2.3.2. Etiology
It has been reported in people working in prefabricated panel production and automobile
industry. Moreover, it may be seen in ready-mixed concrete workers [43–45], engine drivers,
roofers, and coal tar workers [10]. Oil mist exposure has also been considered a cause of
industrial disease, and cases with systemic toxicity and oil acne have been reported to be
associated with the oil mist exposure [46]. Actors (applying stage make-up), fast food workers
(McDonald ’s acne), and workers applying the facemask for prolonged periods as part of their
jobs are at a high risk [10]. Acneiform eruptions have been reported more commonly in marine
engineers, compared to other seaman due to the use of solvents or diesel fuel as hand cleanser
and these lesions were reported to be oil acne [47]. Impure paraffin oil mixtures are the most
widely available acnegen chemical agents with a varying degree of acnegen capacity, and they
are commonly used in the engineering industry [43]. Brilliantine also shows similar effects due
to their impure paraffin content [48]. Concentrated mineral oil is an emulsion of water in oil
containing additives and water. Organic substrates and water constitute an environment for
the microbial growth. Bacterial endotoxins are, therefore, commonly detected in the metal-
working fluids. In a study investigating the exposure to biological agents in the metal-working
industry in Poland, oil acne on the skin was reported [49].
2.3.3. Pathogenesis
Exposure to solvent and grease oil causes mechanical obstruction of pilosebaceous glands and
development of oil acne [50].
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2.3.4. Clinical features
The typical clinical findings are comedones and inflammatory lesions in the dorsum of hand
and extensor surfaces of the arm [1]. Clinical presentation, lesions often involve the arms and
thighs, depending on the contact of the oily clothing [10]. Of note, males are more commonly
affected than females. This can be attributed to the fact that males are more vulnerable to the
development of acne [43]. Comedones and cysts associated with the use of brilliantine can be
found in the retroauricular area, unless rinsed thoroughly [48].
2.3.5. Treatment
Previous studies reported favorable effects of systemic tetracycline for 3 months in the
treatment of oil acne [51]. Isotretinoin is also known to play a role in the treatment of oil acne
[52]. Avoiding contact is also one of the prevention methods. [1] Additional protective
measures may be also required, such as changing cloths and showering on a daily basis.
Improved engineering control with a more emphasis on personal hygiene, there has been a
decline in the prevalence of oil acne, compared to the previous years [10].
3. Conclusion
When the literature was reviewed, it was observed that occupational acne is a severe health
problem. The improvement in working conditions, taking preventive measures, and educa-
tion of the workers could eliminate occupational acne as a problem.
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